Showing results (31-40 of 421) with videos related to

Sort By:
Pageof 43
Lancet (London, England)|January 28, 1995
alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpuraM Galbusera, P Ruggenenti, M Noris, et al.
Journal of the American Society of Nephrology : JASN|June 30, 1998
Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritisS Tomasoni, M Noris, S Zappella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 1999
Renoprotection by nitric oxide donor and lisinopril in the remnant kidney modelA Benigni, C Zoja, M Noris, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
An unanticipated role for survivin in organ transplant damageP Cassis, S Solini, N Azzollini, et al.
Biochemical and Biophysical Research Communications|June 10, 1998
Identification of a novel gene--SSK1--in human endothelial cells exposed to shear stressR Donadelli, L Benatti, A Remuzzi, et al.
Kidney International|July 28, 2001
Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritisC Zoja, A Benigni, M Noris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1996
Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injuryM Noris, P Ruggenenti, M Todeschini, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2013
Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutationsM Alberti, E Valoti, R Piras, et al.
Journal of Lipid Research|December 1, 1989
Development of a mass spectrometric method to quantitate platelet activating factor in mouse urineE Benfenati, D Macconi, M Noris, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic PurpuraM Noris, P Ruggenenti, A Perna, et al.
Pageof 43